Clinical Services market

1
Clinical Services Market Trends, Size, Share,
Demands, Overview, Growth, Revenue and Forecast
to 2030
sales_at_delvens.com www.delvens.com
2
Sternal Closure Systems Market Trends Forecast
Till 2030
Clinical Services Market, By Test Type (Clinical
Chemistry, Immunology, Cytology, Genetics,
Microbiology, Haematology, and Other Test Types),
Service Provider (Hospital-Based Laboratories,
Independent Laboratories, and Other Service
Providers), and region (North America, Europe,
Asia-Pacific, Middle East and Africa and South
America).
Request For Free Sample Report
https//www.delvens.com/get-free-sample/clinical-s
ervices-market
sales_at_delvens.com
www.delvens.com
3
Market Overview
The Clinical services market has experienced
significant growth, driven by various factors
including the impact of the COVID-19 pandemic,
rising incidence of chronic and infectious
diseases, and increasing demand for accurate
diagnostic techniques. During the pandemic, there
was a surge in clinical diagnostics and testing
technologies, exemplified by Thermo Fisher
Scientific's launch of the TaqPath COVID-19 HT
Kit, which enhanced testing capacity globally.
Although the market has returned to pre-pandemic
levels in terms of service demand, ongoing growth
is anticipated. Chronic diseases like cancer and
tuberculosis (TB) continue to impose a
substantial burden globally, underscoring the
critical role of clinical diagnostic tests in
early disease detection and management. For
example, the World Health Organization reported
that millions worldwide are affected by TB,
highlighting the need for robust diagnostic
services. Similarly, cancer cases are on the
rise, with estimates suggesting a significant
increase in new cases by 2040, necessitating
advanced diagnostic capabilities. Purchase
this Report https//www.delvens.com/checkout/clin
ical-services-market
sales_at_delvens.com
www.delvens.com
4
Key Findings
The Clinical Services market is segmented into
Test type, Service Provider On the basis of
Test type, in 2023, the clinical chemistry
segment dominated the market with a significant
revenue share of 54.9. This segment's leadership
is driven by its integral role in pathology
analysis, encompassing tests on body fluids like
urine, plasma, and serum. Key tests include
glucose, creatinine, urea, and various enzymes,
analysed using techniques such as
spectrophotometry and immunoassay. On the basis
of Service Provider, in 2023, hospital-based
laboratories commanded the largest share of the
market at 52.4, driven by their capacity to
handle a high volume of tests for complex and
severe diseases, which are typically more
cost-intensive. This dominance is expected to
persist as more hospitals integrate laboratories
within their premises and expand outreach
programs to cater to patients with critical
conditions.
sales_at_delvens.com
www.delvens.com
5
Key Findings
The market is also divided into various regions
such as North America, Europe, Asia-Pacific,
South America, and Middle East and Africa. North
America is estimated to account for the largest
market share during the forecast period. Inquire
Before Buying https//www.delvens.com/Inquire-bef
ore-buying/clinical-services-market
sales_at_delvens.com
www.delvens.com
6
Competitive Landscape

• The Laboratory Glassware Co.
• Laboratory Corporation of America Holdings
• Fresenius Medical Care AG Co. KGaA
• QIAGEN
• Quest Diagnostics Incorporated
• Siemens Healthcare Private Limited
• Tulip Diagnostics
• Sonic Healthcare Limited
• Merck KGaA
• Myriad Genetics, Inc.
• Bionano Genomics Inc.

• Abbott
• Illumina Inc.
• ARUP Laboratories
• OPKO Health, Inc.
• Bioscientia Healthcare GmbH
• Charles River Laboratories
• NeoGenomics Laboratories
• Genoptix, Inc.
• Healthscope
• Eurofins Scientific

sales_at_delvens.com
www.delvens.com
7
Recent Developments
In August 2023, Laboratory Corporation of America
Holdings (Labcorp) announced an agreement to
acquire Tufts Medicine Outreach Laboratory
Business. This strategic move aims to expand
Labcorp's diagnostic testing and laboratory
services, enhancing its capabilities in
healthcare diagnostics and strengthening its
market position. In September 2022, Bionano
Genomics Inc. launched Bionano Laboratories,
integrating Bionano's optical genome mapping
(OGM) data services with Lineagen's clinical
testing services. This initiative includes the
debut of Bionano Laboratories' first
laboratory-developed test (LDT) based on OGM
technology.
sales_at_delvens.com
www.delvens.com
8
Contact Information
About Us Delvens is a strategic advisory and
consulting company headquartered in New Delhi,
India. The company holds expertise in providing
syndicated research reports, customized research
reports and consulting services. Delvens
qualitative and quantitative data is highly
utilized by each level from niche to major
markets, serving more than 1K prominent companies
by assuring to provide the information on
country, regional and global business
environment. We have a database for more than 45
industries in more than 115 major countries
globally. Contact Us 44-20-3290-6466 1
214-377-1144 sales_at_delvens.com
sales_at_delvens.com
www.delvens.com